NCT05223608 2026-03-18
ImmuCCo
Centre Oscar Lambret
Phase NA Recruiting
Clinical Trials
10 trialsNCT04928508 2026-03-05
Okgyn1
University of Oklahoma
Phase 1 Recruiting
NCT06772090 2026-02-03
Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies
Masonic Cancer Center, University of Minnesota
Phase NA Not yet recruiting
NCT06383884 2025-12-15
Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion
Samsung Medical Center
Phase 2 Recruiting
NCT02220556 2025-08-08
CTC-CEC-ADN
Institut Curie
Phase NA Completed
NCT03410121 2025-08-05
PACPAC-EPOC
Center Eugene Marquis
Phase NA Completed
NCT03772561 2025-07-22
MEDIPAC
National University Hospital, Singapore
Phase 1 Recruiting
NCT04899505 2025-05-16
ODORAJA
Institut Curie
Completed
NCT05620472 2025-04-09
Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1
Tomsk National Research Medical Center of the Russian Academy of Sciences
Phase 1 Completed
NCT06895733 2025-03-26
Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)
Tianjin Medical University Second Hospital
Phase 1/2 Recruiting